ChromoGenics receives order of approximately 250 TSEK for ConverLight dynamic glass to Regal Förvaltning AB

ChromoGenics AB (publ) has signed an agreement with Regal Förvaltning AB to deliver ConverLight® to an office in Uppsala.

Regal Förvaltning AB has chosen ConverLight dynamic glass for one of its offices in Uppsala with delivery in autumn 2018.

“The office has previously had extensive problems with high heat radiation and an excessively warm indoor climate with a deficient working environment. We have previously tried to solve it with exterior solar protection, but since installation and maintenance costs for awnings or similar solutions are often high as well as changing the building’s façade and blocking the daylight, ConverLight became an obvious choice,” says Anders Jonsson, owner of Regal Förvaltning AB.

“We are proud that Regal Förvaltning AB chose ConverLight dynamic glass for one of its offices in Uppsala. ChromoGenics’ dynamic glass automatically controls the heat and daylight emitted in buildings, providing increased indoor comfort. The order demonstrates the need for energy efficient and maintenance-free solar control solutions with maintained views and daylight,” says Jerker Lundgren, CEO of ChromoGenics.

Jerker Lundgren, CEO 
Susanne Andersson, CFO and Head of Communications
Tel: +46 (0)18 430 0430

Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation.

About ChromoGenics
ChromoGenics offers dynamic glass with controllable heat- and light transmission. The company’s unique technology ConverLight® provides sustainable solar control for increased indoor comfort and energy efficiency. ConverLight® also contributes to Green Building certifications. In 2016 the company started commercial sales to real estate projects in Scandinavia.

ChromoGenics is located in Uppsala, Sweden, and the technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser. 

Download as PDF


Subscribe to our news